Prostate-Specific Membrane Antigen-Based Therapeutics
Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. While significant therapeutic advances have been made, available systemic therapeutic options are lacking. Prostate-specific membrane antigen (PSMA) is a highly-re...
Saved in:
Main Authors: | Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell, Scott T. Tagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/973820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015-11-01) -
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
by: Ilham Badrane, et al.
Published: (2024-12-01) -
Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01) -
Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen
by: William Derval Aiken, et al.
Published: (2015-01-01)